Skip to main content
Back
Watch Compare

GENELUX Corp

Data quality: 100%
GNLX
Nasdaq Manufacturing Chemicals
$2.41
▼ $0.24 (-8.90%)
Mkt Cap: 107.76 M
Price
$2.41
Mkt Cap
107.76 M
Day Range
$2.31 — $2.89
52-Week Range
$2.21 — $8.54
Volume
816,234
Open $2.72
50D / 200D Avg
$2.64
8.96% below
50D / 200D Avg
$3.85
37.57% below

Quick Summary

Key Takeaways

Negative free cash flow of -26.37 M
Capital intensive — 13725.00% of revenue goes to capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)0.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-151.31%
Below sector avg (-53.41%)
ROIC-116.31%
Net Margin-401812.50%
Op. Margin-415175.00%

Safety

Debt / Equity
N/A
Current Ratio4.20
Interest CoverageN/A

Valuation

PE (TTM)
-3.35
Below sector avg (-1.48)
P/B Ratio5.80
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -3.4 -1.5
P/B 5.8 1.6
ROE % -151.3 -53.4
Net Margin % -401812.5 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 0.00% Revenue Growth (3Y) -78.31%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 8,000.0 Net Income (TTM) -32.15 M
ROE -151.31% ROA -112.33%
Gross Margin N/A Operating Margin -415175.00%
Net Margin -401812.50% Free Cash Flow (TTM) -26.37 M
ROIC -116.31% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.20
Interest Coverage N/A Asset Turnover 0.00
Working Capital 16.43 M Tangible Book Value 18.59 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.35 Forward P/E N/A
P/B Ratio 5.80 P/S Ratio 13469.75
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -24.47%
Market Cap 107.76 M Enterprise Value 107.76 M
Per Share
EPS (Diluted TTM) -0.86 Revenue / Share 0.00
FCF / Share -0.59 OCF / Share -0.56
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 13725.00% FCF Conversion 82.02%
SBC-Adj. FCF -32.22 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 8,000.0 8,000.0 170,000.0
Net Income -32.15 M -29.87 M -28.30 M
EPS (Diluted) -0.86 -0.95 -1.16
Gross Profit — — —
Operating Income -33.21 M -31.70 M -24.17 M
EBITDA — — —
R&D Expenses 19.85 M 19.00 M 12.77 M
SG&A Expenses — — —
D&A — — —
Interest Expense — 173,000.0 —
Income Tax — — 1.10 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 19.03 M 34.72 M 27.89 M
Total Liabilities 7.48 M 8.44 M 8.42 M
Shareholders' Equity 11.54 M 26.27 M 19.47 M
Total Debt — 900,000.0 900,000.0
Cash & Equivalents 5.33 M 8.57 M 9.42 M
Current Assets 15.13 M 31.55 M 24.20 M
Current Liabilities 6.23 M 6.90 M 6.55 M